C30H34N8
506.6 g/mol
APIWarning
Bemcentinib
CAS1037624-75-1
Category
API
Compound Class
Amine
Primary Use
Pharmaceutical Raw Material
Bemcentinib is an experimental oral small molecule that acts as an inhibitor of AXL kinase. It is being investigated in Phase II clinical trials for various solid and hematological tumors, both as monotherapy and in combination with other treatments.
research compound for AXL kinase inhibition studiespharmaceutical raw material for oncology research
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1037624-75-1
Related Compounds
ReferenceSame Category
Gimeracil
CAS103766-25-2
pharmaceutical raw material
ReferenceSame Category
Hydrocortisone EP Impurity I
CAS103795-84-2
pharmaceutical raw material
ReferenceSame Category
Bromotheophylline
CAS10381-75-6
pharmaceutical raw material
ReferenceSame Category
Lacidipine
CAS103890-78-4
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine
InChIKey
KXMZDGSRSGHMMK-VWLOTQADSA-N
SMILES
C1CCN(C1)[C@H]2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76
Synonyms (23)
- R428
- W-5845
- Bemcentinib (USAN/INN)
- AXL Inhibitor BGB324
- BGB 324; R 428
- Bemcentinib
- Bemcentinib (GMP)
- Bemcentinib (R428)
- BemcentinibR428BGB324)
- R-428 compound
- R428 (BGB324)
- bemcentinibum